¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Nasal Allergy Control Nasl"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • nasal cartilage graft
    ÄÚ¿¬°ñÀ̽Ä
  • nasal cavity
    ÄÚ¾È, ºñ°­
  • nasal concha
    ÄÚ¼±¹Ý, ºñ°©°³
  • nasal concretion
    ÄÚµ¹, ÄÚ°á¼®
  • nasal crest
    Äڴɼ±
  • nasal cycle
    ÄÚ¼øÈ¯°úÁ¤, ÄÚÁÖ±â
  • nasal discharge
    Ä๰, ºñ·ç
  • nasal feeding
    ÄÚ°æÀ¯¿µ¾ç(¹ý)
  • nasal flaring
    ÄÚ¹ú··ÀÓ
  • nasal furuncle
    ÄÚÁ¾±â
  • nasal gland
    ÄÚ»ù, ºñ¼±
  • nasal hemianopia
    ÄÚÂʹݸÍ
  • nasal hemorrhage
    ÄÚÇÇ, ºñÃâÇ÷
  • nasal implant
    ÄÚ»ðÀÔ¹°
  • nasal inhaler
    ÄÚÈíÀÔ±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • external nasal nerve
    ¹Ù±ùÄڽŰæ
  • nasal feeding
    °æºñ¿µ¾ç¹ý, ÄÚ±Þ½Ä
  • nasal furuncle
    ÄÚÁ¾±â
  • nasal bone fracture
    ÄÚ»À°ñÀý
  • nasal gland
    ÄÚ»ù
  • nasal cartilage graft
    ÄÚ¿¬°ñÀ̽Ä
  • nasal hemianopia
    ÄÚÂʹݸÍ
  • nasal hemorrhage
    ÄÚÇÇ
  • nasal implant
    ÄÚ»ðÀÔ¹°
  • nasal inhaler
    ÄÚÈíÀÔ±â
  • nasal irrigator
    ÄÚ¼¼Ã´±â
  • nasal rim incision
    ÄÚÅ׵θ®Àý°³
  • lateral nasal prominence
    °¡ÂÊÄÚÀ¶±â
  • nasal labyrinth
    Äڹ̷Î
  • medial nasal prominence
    ¾ÈÂÊÄÚÀ¶±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • immediate allergy
    Áï½Ã¼º¾Ë·¹¸£±â,Á÷Á¢¾Ë·¹¸£±â(ÇǺÎ)Áï½ÃÇü¾Ë·¹¸£±â
  • immediate allergy
    Áï½Ã¼º ¾Ë·¹¸£±â, Á÷Á¢¾Ë·¹¸£±â.[ÇǺÎ]Áï½ÃÇü( ãÁû¡)¾Ë ·¹¸£
  • impulse control disorder
    Ãæµ¿ Á¶ÀýÀå¾Ö, ~º´
  • impulse-control disorder
    Ãæµ¿Á¶ÀýÀå¾Ö
  • induced allergy
    À¯¹ß(¼º)¾Ë·¹¸£±â.
  • induced allergy
    À¯¹ß(¼º)¾Ë·¹¸£±â
  • infection allergy
    °¨¿°(Êïæø)¾Ë·¹¸£±â.
  • infection control study
    °¨¿°°ü¸®¿¬±¸
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • injury control
    »óÇØ°ü¸®(Ë×Ì´Ë´Ëö).
  • physical allergy
    ¹°¸®Àû ¾Ë·¹¸£±â(Úª×âîÜ¡­)
  • physical allergy
    ¹°¸®Àû ¾Ë·¹¸£±â.
  • pollen allergy
    Áµa·ç<È­ºÐ>¾Ë·¹¸£±â.
  • predictive value of control signal
    Á¦¾î<´ëÁ¶>½ÅÈ£ÀÇ ¿¹ÃøÄ¡
  • pulse control unit
    ¸Æ¹Ú Á¶Àý ´ÜÀ§
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • dust allergy
    ¸ÕÁö¾Ë·¹¸£±â.
  • erythron allergy
    ÀûÇ÷±¸°è ¾Ë·¹¸£±â.
  • food allergy
    ½Ä¹°<½Ä»ç>¼º ¾Ë·¹¸£±â.
  • food allergy
    ½Ä¹°<½Ä»ç>¼º ¾Ë·¹¸£±â.
  • gastrointestinal allergy
    À§Àå°ü¾Ë·¹¸£±â.
  • heat allergy
    ¿­¾Ë·¹¸£±â.
  • immediate allergy
    Áï½Ã¼º ¾Ë·¹¸£±â, Á÷Á¢¾Ë·¹¸£±â.[ÇǺÎ]Áï½ÃÇü( ãÁû¡)¾Ë ·¹¸£
  • immediate allergy
    Áï½Ã¼º¾Ë·¹¸£±â,Á÷Á¢¾Ë·¹¸£±â(ÇǺÎ)Áï½ÃÇü¾Ë·¹¸£±â
  • induced allergy
    À¯¹ß(¼º)¾Ë·¹¸£±â
  • induced allergy
    À¯¹ß(¼º)¾Ë·¹¸£±â.
  • infection allergy
    °¨¿°(Êïæø)¾Ë·¹¸£±â.
  • insect allergy
    °ïÃæ¾Ë·¹¸£±â.
  • latent allergy
    Àẹ¼º(íÖÜÑàõ) ¾Ë·¹¸£±â.
  • mental allergy
    ½É¸®¼º(ãýìµàõ) ¾Ë·¹¸£±â.
  • milk allergy
    ¿ìÀ¯¾Ë·¹¸£±â.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Superior nasal arteriole of retina
    À§¾ÈÂʸÁ¸·¼Òµ¿¸Æ
    [¿¾ ¿ë¾î] »ó³»Ãø¸Á¸·¼Òµ¿¸Æ
  • Superior nasal venule of retina
    À§¾ÈÂʸÁ¸·¼ÒÁ¤¸Æ
    [¿¾ ¿ë¾î] »ó³»Ãø¸Á¸·¼ÒÁ¤¸Æ
  • Superior nasal concha
    À§ÄÚ¼±¹Ý
    [¿¾ ¿ë¾î] »óºñ°©°³
  • Superior nasal meatus
    À§Äà±æ
    [¿¾ ¿ë¾î] »óºñµµ
  • Secondary nasal septum
    ÀÌÂ÷ÄÚÁß°Ý
    [¿¾ ¿ë¾î] ÀÌÂ÷ºñÁß°Ý
  • Primary nasal septum
    ÀÏÂ÷ÄÚÁß°Ý
    [¿¾ ¿ë¾î] ÀÏÂ÷ºñÁß°Ý
  • Median nasal process
    Á¤ÁßÄÚµ¹±â
    [¿¾ ¿ë¾î] Á¤Áߺñµ¹±â
  • Median nasal process
    Á¤ÁßÄÚµ¹±â
    [¿¾ ¿ë¾î] Á¤ÁߺñÀ¶±â
  • Middle nasal concha
    Áß°£ÄÚ¼±¹Ý
    [¿¾ ¿ë¾î] Áߺñ°©°³
  • Middle nasal meatus
    Áß°£Äà±æ
    [¿¾ ¿ë¾î] Áߺñµµ
  • Atrium of middle nasal meatus
    Áß°£Äà±æ¾Õ¹æ
    [¿¾ ¿ë¾î] ÁߺñµµÀü¹æ
  • Nasal spine
    ÄÚ°¡½Ã
    [¿¾ ¿ë¾î] ºñ±Ø
  • Nasal placode
    ÄÚ±â¿øÆÇ
    [¿¾ ¿ë¾î] ºñÆÇ
  • Nasal crest
    Äڴɼ±
    [¿¾ ¿ë¾î] ºñ¸ª
  • Nasal surface
    ÄÚ¸é
    [¿¾ ¿ë¾î] ºñ°­¸é
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
alg allergy
all allergy, allergic
AND algoneurodystrophy; anterior nasal discharge
ANS acanthion; American Nutrition Society; 8-anilino-1-naphthalene-sulfonic acid; anterior nasal spine; ...
ASA acetylsalicylic acid; active systemic anaphylaxis; Adams-Stokes attack; American Society of Anesthes...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
LNIT Local nasal immunotherapy
N Nasal
NCPAP Nasal Continuous Positive Airway Pressure
NIPPV Nasal Intermittent Positive Pressure Ventilation
NPT Nasal Provocation Test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • plaque control
    ġŠÁ¶Àý
  • proper direction and control
    ÀûÀýÇÑ Áöµµ¿Í ÅëÁ¦
  • pulse control unit
    ¸Æ¹Ú Á¶Àý ´ÜÀ§
  • quality control program
    Á¤µµ °ü¸® °èȹ
  • reasonable emotional control
    ÇÕ¸®Àû Á¤¼­ Á¶Àý
  • regular control
    ±ÔÄ¢ÀûÀÎ Á¶Àý
  • self-control
    ÀÚ°¡ Á¶Àý¹ý
    °³ÀÎÀÇ ½Å³ä ¸ñÇ¥ ¹× ŵµ¿¡ µû¶ó¼­ ÀÚ±âÀÇ ÇൿÀ» ½º½º·Î Á¶ÀýÇÏ´Â °Í.
  • stringent control
    ¾ö°Ý Á¶Àý
  • sulfur dioxide control
    ÀÌ»êÈ­ Ȳ °¡½º ±ÔÁ¦
  • time gain control
    ½Ã°£ °ÔÀÎ Á¶Àý
  • venereal disease control
    ¼ºº´ °ü¸®
  • voice control
    À½¼º Á¶Àý
    ¸ñ¼Ò¸®¸¦ ÀÓÀÇ·Î Á¶ÀýÇÏ´Â °Í.
  • voluntary control
    ÀǽÄÀû Á¦¾î, ÀÇÀÇÀû Á¶Àý
  • water quality control
    ¼öÁú °ü¸®
  • accessory nasal cavity
    ºÎºñ°­
    Äà¼Ó¿¡ À̾îÁ® ÁÖÀ§ÀÇ »À ¼Ó¿¡ À̾îÁ® ÀÖ´Â »ó¾Çµ¿, ÀüµÎµ¿, »ç°ñµ¿ µîÀÇ ÃÑĪ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
gate-control theory A theory to explain the mechanism of pain; small fibre afferent stimuli, particularly pain, entering the substantia gelatinosa can be modulated by large fibre afferent stimuli and descending spinal pathways so that their transmission to ascending spinal pathways is blocked (gated).
Synonym: gate-control hypothesis.
(05 Mar 2000)
case-control study <epidemiology> A study in which the risk factors of people with a disease are compared with those without a disease.
It is an epidemiological method that begins by identifying persons with the disease or condition of interest (the cases) and compares their past history of exposure to identified or suspected risk factors with the past history of similar exposures among persons who resemble the cases but do not have the disease or condition of interest (the controls).
The relationship of an attribute to the disease can therefore be examined by comparing affected and non-affected individuals with regard to the frequency or levels of the attribute in each group.
(05 May 2002)
vestibulo-equilibratory control Nerve impulses transmitted from the saemicircular canals, saccule, and utricle that serve to maintain the equilibrium of the body.
(05 Mar 2000)
reflex control Nerve impulses transmitted to the muscles to maintain normal reflex action.
(05 Mar 2000)
relaxed control The ability of certain plasmids to continue to replicate after their bacteria stop dividing, theresult is a single bacteria that containshundreds of plasmids.
(09 Oct 1997)
Centers for Disease Control and Prevention <organisation> The U.S. Public health agency serving as the centre for preventing, tracking controlling and investigating the epidemiology of AIDS and other diseases.
(26 Mar 1998)
reproductive control agents Substances used either in the prevention or facilitation of pregnancy.
(12 Dec 1998)
Centres for Disease Control The federal facility for disease eradication, epidemiology, and education headquartered in Atlanta, Georgia, which encompasses the Centre for Infectious Diseases, Centre for Environmental Health, Centre for Health Promotion and Education, Centre for Prevention Services, Centre for Professional Development and Training, and Centre for Occupational Safety and Health. Formerly named Centre for Disease Control (1970), Communicable Disease Centre (1946).
(05 Mar 2000)
centres for disease control and prevention See: CDC.
(12 Dec 1998)
riot control agents, chemical Chemical substances which are employed during a riot in order to control or disperse the rioting parties.
(12 Dec 1998)
growth control <cell biology> When applied to cells usually means control of growth of the population, i.e. Of the rate of division rather than of the size of an individual cell.
(18 Nov 1997)
pest control The reduction or regulation of the population of noxious, destructive, or dangerous insects or other animals.
(12 Dec 1998)
pest control, biological The use of biological mechanisms, usually involving living organisms such as bacteria, for the reduction or regulation of the population of noxious, destructive, or dangerous pests. Environmental concerns have focused attention on natural forms of disease control as potentially safe and effective alternatives to chemical pesticides. This has led to increased efforts to develop control strategies that rely on natural predators and parasites or that involve genetically engineered microbial pest control agents.
(12 Dec 1998)
rodent control The reduction or regulation of the population of noxious, destructive, or dangerous rodents through chemical, biological, or other means.
(12 Dec 1998)
weed control <botany> Mechanical or chemical control of unwanted plants. Measures which have to be undertaken in a plant community to guarantee the growth of the desired vegetation.
See: herbicide.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • damage control
    ÀÀ±Þ ÇÇÇØ ´ëÃ¥;ÇÇÇØ ´ëÃ¥¹Ý
  • dual control
    ÀÌÁß °üÇÒ;¾ç±¹ °øµ¿ ÅëÄ¡;(°ø)ÀÌÁß Á¶Á¾ ÀåÄ¡
  • exchange control
    ȯ°ü¸®
  • fingertip control
    ¹öư Á¶Á¾(ÀåÄ¡)
  • fire control
    »ç°ÝÁöÈÖ
  • fire control radar
    È­±â °üÁ¦ ·¹ÀÌ´õ
  • flight control
    °üÁ¦¼Ò
  • flood control
    Ä¡¼ö
  • food control
    ½Ä·® °ü¸®(ºñ»ó½ÃÀÇ)
  • gain control
    (ÀüÀÚ)(¼ö½Å±â,Á߯ø±âÀÇ)À̵æ Á¦¾î
  • ground control
    (ºñÇàÀåÀÇ)Áö»ó °üÁ¦(°ü)
  • light control
    µîÈ­ °üÁ¦
  • mission control
    (Áö»óÀÇ) ¿ìÁÖ ºñÇà °üÁ¦ ¼¾ÅÍ
  • numerical control
    (Àü»ê)¼öÄ¡Á¦¾î(µðÁöÅ» °è»ê±â¿¡ ÀÇÇÑ °øÀÛ ±â°èÀÇ Á¦¾î)
  • price control
    ¹°°¡ ÅëÁ¦
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á